Nfj Investment Group, LLC Bristol Myers Squibb CO Transaction History

Nfj Investment Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $4,283 - $4,790	-74 Reduced 0.23%	32,522 $1.89 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $261,147 - $289,963	4,099 Added 14.38%	32,596 $2.08 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $7,096 - $8,049	-108 Reduced 0.38%	28,497 $1.98 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $12.5 Million - $14.8 Million	-181,955 Reduced 86.41%	28,605 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $23,029 - $13.6 Million	177,153 Added 530.29%	210,560 $7.08 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $7,842 - $8,637	-108 Reduced 0.32%	33,407 $2.57 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $44,388 - $53,225	722 Added 2.2%	33,515 $2.45 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $94,335 - $109,972	-1,759 Reduced 5.09%	32,793 $2.05 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $41,241 - $48,309	-697 Reduced 1.98%	34,552 $2.04 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $220,028 - $239,610	-3,554 Reduced 9.16%	35,249 $2.36 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $2.3 Million - $2.59 Million	38,803 New	38,803 $2.45 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Nfj Investment Group, LLC with notifications on news.